Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and Calcium Supplementation for BPPV Recurrence Prevention
NCT02031692Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Dec 2013
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vitamin d and calcium carbonate in benign paroxysmal positional vertigo (BPPV) (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Recurrence frequency of benign paroxysmal positional vertigo at 1 year. Started Dec 2013; status: completed.
02
Drugs
vitamin dcalcium carbonate
03
Conditions
benign paroxysmal positional vertigo (BPPV)
Beyond the preview
Go deeper on NCT02031692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02031692.